The Anticoagulant Therapy and International Normalized Ratio Monitoring after the Mechanical Heart Valve Replacement

唐跃,吴清玉,董超,孙寒松,潘世伟,刘真,唐棣,孙淑珍
DOI: https://doi.org/10.3760/j:issn:0253-3758.2003.06.009
2003-01-01
Abstract:Objective To identify whether or not the commonly used anticoagulant regimen and the standard of international normalized ratio (INR) achieved the ideal anticoagulant effect after mechanical heart valve replacement. Methods Between September 2000 and May 2002, 61 patients with valvular diseases were investigated prospectively. Among them, 34 cases were mitral valve diseases, 11 were aortic valve diseases, 16 were double valve diseases. Seventy-seven CarboMedics valves were implanted in all patients. The load dosage of warfarin was used for anticoagulation in the first 2 days and then reduced to the maintaining dosage in the following 2 days. The INR was tested every 24 hours in the 8 days after operation. After discharge, the specifying staffs took the responsibility for the follow-up and the INR was tested 14 times according to the designed interval. The observed items included hemorrhage, thrombosis, death and so on. All data was collected into the special data bank and processed by SPSS 10.0 statistic program. Results There was no hospital death. Only one cerebral embolism occurred in the hospitalization period (1.8%). All 61 patients were followed up. Mean follow-up period was (8.6 ±4.7) months (0.5 to 20 months) with a total of 523 patient-months (44 patient-years). One patient died of severe heart failure 8 months after operation. The other one occurred stomach bleeding 10 months after operation. No thromboembolism complication occurred. The five-year survival rate was (83.0±2.3)%. Freedom from bleeding event at 5 years was (83.0±2.3)%. Conclusions The commonly used anticoagulant regimen for mechanical heart valve replacement was simple and effective. The load dosage of warfarin in the first 2 days was 5 mg per day, and reduced to 4.2 mg per day in the third day and 3.4 mg per day (nearly maintaining dosage) in the fourth day, respectively. Long-term maintaining dosage of warfarin was (3.6±0.5) mg per day. The INR range of 1.6-2.6 was relatively safe. The ideal target INR range of 1.8~2.5 is recommended.
What problem does this paper attempt to address?